You are here: Industry Insights > Viatris

News List

Biocon Biologics and Viatris receive US FDA approval for maiden interchangeable biosimilar Semglee expresspharma
July 30, 2021
Interchangeable designation allows substitution at the pharmacy counter for Lantus across the US to help increase access to medicines for people living with diabetes.
Biocon Biologics, Viatris get EC approval for biosimilar Bevacizumab expresspharma
April 27, 2021
Abevmy 100 and 400 mg is approved for the treatment in metastatic colorectal carcinoma, metastatic breast cancer, non small-cell lung carcinoma, glioblastoma, ovarian, cervical and renal cancer as part of a specific regimen.
FDA Grants Tentative Approval to Generic Version of Symbicort contractpharma
March 10, 2021
Product is indicated for certain patients with asthma or chronic obstructive pulmonary disease (COPD).
Biocon Biologics and Viatris get CHMP Nod for Abevmy expresspharma
March 01, 2021
Biocon Biologics, a subsidiary of Biocon announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the marketing authoris ation of their biosimilar Bevacizumab ...
Biocon Biologics and Viatris get EC Approval for Kixelle, biosimilar insulin Aspart expresspharma
February 18, 2021
Kixelle, a fast-acting insulin analog indicated for the treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above, has been approved as a 100 units/ml solution for injection in vial and pre-filled pen presentations.
Mylan Appoints Head of Capital Markets contractpharma
November 04, 2020
Bill Szablewski joins the company from Bristol Myers Squibb where he served as Assistant Treasurer, Capital Markets.
Mylan to acquire thrombosis business in Europe from Aspen Pharmacare for EUR 641.9 mn expresspharma
September 17, 2020
Transaction expected to be immediately accretive to Mylan upon closing and is anticipated to be accretive to VIATRIS.
Pfizer, Mylan Announce Two Future Viatris Board Members americanpharmaceuticalreview
December 20, 2019
Pfizer and Mylan announced Ian Read and James Kilts will join the Viatris board of directors upon completion of the planned combination of Mylan N.V. and Upjohn Inc. ...